baber/WOPTO huggingface dataset:
Patent JP-2000503525-A (JP)
IPC: C12P21/02
Filed: 1996-03-12
Abstract: The present invention provides novel nucleic acid molecules coding for sigma subunits of Mycobacterium tuberculosis RNA polymerase. It also relates to polypeptides, referred to as SigA and SigB, encoded by such nucleic acid molecules, as well as to vectors and host cells transformed with the said nucleic acid molecules. The invention further provides screening assays for compounds which inhibit the interaction between a sigma subunit and a core RNA polymerase.
Patent JP-2000510638-A (JP)
Title: 多重極子質量分光計の軸方向射出方法
IPC: H01J49/42
Filed: 1997-06-02
Abstract: (57)【要約】
細長い多重極子ロッド・セットを有し、２次元ＲＦ電界が注目する質量−電荷比範囲にあるトラップされたイオンをロッド・セット内で半径方向に封じ込め、軸方向にはイオンは出射レンズの障壁電界により封じ込められ、さらにロッド・セットには低ＤＣ電圧が印加される、質量分光計の動作方法。トラップされたイオンは、出射レンズ近傍のフリンジ電界及びその他の反調和性により誘起される自由度混合を利用することにより、質量選択的に軸方向に射出される。よって、ロッド・セットの入射端内にイオンが入れられると同時に出射端でイオンが質量選択的に射出されることにより、連続イオン源からのイオン束をよりよく利用できる。軸方向の質量選択的射出は、出射レンズに補助ＡＣ電圧を印加し、補助ＡＣ電圧またはロッド・セットのＲＦ電圧をスキャンすることにより行われる。トラップされたイオンは、レンズ方向に向かう軸方向電界を印加することにより出射レンズ近くに集中するか、あるいは反対方向に向かう軸方向電界を印加することにより減じる。軸方向電界は、トラップされたイオンを解離するため振動させることができる。
Patent JP-2000512129-A (JP)
Title: ブタレトロウィルス
IPC: C12N15/48
Filed: 1997-04-18
Abstract: (57)【要約】
本発明は、ブタレトロウイルス（porcine retrovirus，PoEV）ポリヌクレオチド断片、特に、少なくとも一つのブタレトロウィルス発現体を符号化するもの、少なくとも一つのポリヌクレオチド断片を含む組換えベクター、生来的ブタレトロウィルスを検出するためにPoEVポリヌクレオチド断片を使用すること、少なくとも一つのPoEVポリヌクレオチド断片を含む宿主細胞、もしくは少なくとも一つのPoEVポリヌクレオチド断片を含む組換えベクター、PoEVポリペプチド、PoEVポリペプチドに対して免疫反応を示す抗体、予防剤および／または治療剤として使用する組換えPoEVポリペプチドを含む薬剤組成物、および、PoEVポリヌクレオチド断片および／またはPoEVポリペプチドを、獣医学を含む医学に、およびこれらの医学に用いる薬剤の調合に用いること、を提供する。
Patent JP-H11509706-A (JP)
Title: ディジタルテレビジョンの同期化
IPC: H04L7/027
Filed: 1997-04-21
Abstract: (57)【要約】
複数の既知のビデオフォーマットに従ってビデオシステムを複数の複合同期信号のうちの１つに自動的に同期させる装置が、多数のタイプの複合同期信号にそれぞれ対応する多数の同期信号分離回路と、各タイプの複合同期信号に対する各既知の水平同期信号レート用の識別回路に対応する複数の水平同期信号標準方式識別回路を有して、おおよその水平同期信号レートを測定する水平同期アナライザと、種々の既知の垂直同期信号レートの数に対応する複数の垂直同期信号レート識別回路を有して、垂直同期信号レートを測定する垂直同期アナライザとを具えている。
Patent JP-2000509513-A (JP)
Title: 光ネットワーク装置（ｏｎｕ）用の機械式密閉箱
IPC: H04B10/00
Filed: 1997-04-29
Abstract: (57)【要約】
光ネットワーク装置（ONU）用の機械式密閉箱（100）は、第１の開口とこの開口の反対側の第２の開口とを有するフレーム（101）を含む。このフレームを、前記ONUの電子回路および光回路を収容する第１の区画（102）と、前記ONUの端子板および同軸ケーブルポートを収容する第２の区画（103）とに隔壁で分割する。各区画はその区画へのアクセスのための専用扉を有する。この隔壁を通り抜ける各素子には防水シールが設けてあり、それによって電子回路／光回路区画（102）に防水環境を形成する。ドロップケーブルはフレームの第２の区画（103）に保持したグロメット経由でONUから外部に向かう。フック組合せ体は、この密閉箱の前記区画へのアクセスを改善するように互いに異なる位置でこの密閉箱を保持することをさらに可能にする。
Patent JP-2001514652-A (JP)
Title: プレニルアルコールの製造方法
IPC: C07C29/09
Filed: 1998-01-08
Abstract: (57)【要約】
２−メチル−１，３−ブタジエン（イソプレン）及びカルボン酸からの３−メチル−２−ブテン−１−オール（プレニルアルコール）の調製の方法が開示されている。このプロセスで使用し得るカルボン酸は、Ｋ a が１０ -4 より大きい（水に対する相対値）を有しており、ジクロロ酢酸が特に好ましい。このプロセスは、プレニルエステルを生成するためにイソプレンのカルボン酸へのゆっくりとした添加（例えば滴下）を含んでいる。エステル形成反応は、殆どの場合室温で進行し、有機塩基触媒、好ましくは反応剤のカルボン酸のナトリウム塩又はカリウム塩の使用は、収率を高める。結果として生成するプレニルエステルは、塩基との反応によりプレニルアルコールに変換され得る。プレニルアルコールは、ビタミンＡ及びＥ、並びに幾つかの広汎に用いられているカロチノイドの合成に於ける化学中間体であるシトラールに容易に変換され得る。
Patent JP-2001512412-A (JP)
Title: アンモニアを分解するためのゲッタ素材
IPC: H01M8/06
Filed: 1998-03-09
Abstract: (57)【要約】
アンモニアを分解して、水素を生成するための方法を提供する。この方法は、アンモニア分解触媒上をアンモニアを通過させるステップを備える。アンモニア分解触媒は、１）一般式Ｚｒ 1-x Ｔｉ x Ｍ 1 Ｍ 2 を有し、ここで、Ｍ 1 及びＭ 2 はＣｒ、Ｍｎ、Ｆｅ、Ｃｏ、Ｎｉから成る群から独立に選択され、ｘは、約０．０以上約１．０以下の値であるような合金と、（２）約２０重量％ないし約５０重量％の間のＡｌと、を含む合金である。更に、本発明の方法を用いて、水素燃料内燃機関及び水素燃料電池を駆動する方法を提供する。また、本発明は、上述したアンモニア分解触媒を含む水素燃料内燃機関並びに水素燃料電池を提供する。
Patent JP-2001517176-A (JP)
Title: ねじり変形を受けるクロスビームとほぼ垂直なサスペンションばねとを備えた自動車用リヤアクスルの改良
IPC: B60G11/44
Filed: 1998-02-27
Abstract: (57)【要約】
本発明は、各サスペンションばね（６）がＣ字形の弾性片からなり、その下端（６ａ）および上端（６ｂ）が、ばね（６）の中間面に垂直な軸をそれぞれ備えた２個の継手（７；８）でそれぞれ直接保持され、一方（６ａ）が結合アーム（１）に、他方（６ｂ）が自動車のボディ（Ｃ）に結合されることを特徴とする自動車用のリヤアクスルに関する。本発明は、ねじり変形を受けるクロスビームを備えたリヤアクスルに適用可能である。
Patent JP-2001503605-A (JP)
IPC: A23L11/00
Filed: 1997-05-17
Abstract: The description relates to a process for producing cheese, curd or yoghourt products from soya beans involving the steps; (a) preparation of soya milk from soya beans; (b) addition of vegetable sugar to the soya milk in the proportion of 1 to 5 wt %; (c) emulsifying vegetable fats and/or oils in a total proportion of some 15 wt % in the soya milk; (d) preparation of a culture cocktail with a pH between 3.8 and 4.5 by the addition of commercially available cheese cultures and animal lactose in a proportion of some 10 wt % of the vegetable sugar added in step (b) to the soya milk as in step (a); (e) addition of the culture cocktail to the soya milk as per step (c) to curdle it and ferment it as desired, and (f) subsequent ripening and final processing in the prior art manner to provide the desired cheese, curd or yoghourt product.
Patent JP-2001521502-A (JP)
Title: Ｃ型肝炎の治療へのアマンタジンの使用
IPC: A61K31/13
Filed: 1998-03-27
Abstract: (57)【要約】
ウイルス感染患者の薬物治療方法を記載する。1つの実施態様においては、ウイルスがC型肝炎ウイルスであり、医薬がアマンタジン（amantadine）である。本発明の方法は、インターフェロン治療が無効であるか、又はそれに耐えられない患者並びに18才未満の患者において使用できる。
Patent JP-2002504992-A (JP)
Title: リガンド−アミノデキストラン−マーカーコンジュゲート及びその使用
IPC: G01N33/543
Filed: 1998-05-14
Abstract: (57)【要約】
増強された蛍光シグナルを供することにより要求される標的生物材料の検出のために役立つリガンド−アミノデキストラン−（フィコビリプロテイン又はタンデム染料）コンジュゲートが記載される。また、各々の対が各々のレセプターのための標識化リガンドと実質的に同様のレセプター密度で発現される相互に排他的な細胞レセプターを含む細胞集団の異なる対の標識化に基づいて細胞の複数の集団を一回の測定で定量するための方法も記載される。１つの細胞集団は、第１の細胞表面レセプターに結合することができ、かつ蛍光フィコビリプロテイン又はタンデム染料に直接、コンジュゲートしているリガンドで標識され；第２の細胞集団は、第２の細胞表面レセプターに結合することができ、かつ蛍光フィコビリプロテイン又はタンデム染料にアミノデキストランにより架橋されているリガンドで標識される。
Patent MX-155486-A (MX)
Inventor: WINNICKI KALIXT VON
IPC: G05F1/46
Filed: 1984-04-27
Abstract: A current supply device for series-fed electronic circuits has a Zener diode interconnected between the input and the output for the feed current together with a rectifying diode and a charging capacitor, a first controllable impedance being connected between the charging capacitor and the consumer, and a second controllable impedance being connected in parallel with the consumer. Both controllable impedances are driven by a regulator which monitors the voltage supplied to the consumer, and maintains this voltage at a constant level.
Patent NZ-215440-A (NZ)
Title: Compressible dosage package
Inventor: WIDERSTROM C A H M
IPC: B65D1/32
Filed: 1986-03-11
Abstract: Dosage package of a thermoplastic material with a relatively flat container (1), which has a permanently shaped edge wall portion (5) extending all around, as well as two opposite side wall portions (8, 9), which are compressable to discharge a well defined dosage via a discharge tube (2), which joins the edge wall portion (5).
Patent NZ-234683-A (NZ)
Title: Control of scale in aqueous systems using phosphonomethyl amine oxides
Inventor: HWA CHIH MING
IPC: C02F5/14
Filed: 1990-07-27
Abstract: This invention relates to controlling scale formation in aqueous systems and more particularly to using certain calcium insensitive phosphonomethyl amine oxide compounds having at least one oxidized tertiary amine group of the formula: <CHEM> and water soluble salts thereof.
Patent NZ-239970-A (NZ)
Title: Extracting cholesterol from egg yolks - a yolk, oil and water mixture is sheared
Inventor: LOMBARDO STEPHEN P
IPC: A23L15/00
Filed: 1991-09-27
Abstract: A method of removing cholesterol from egg yolk by shearing a mixture of oil:egg yolk:water ratio of about 3:1:0.8 to about 1.5:1:0.4 where the temperature of the mixture during shearing is between about 124 DEG  to about 148 DEG  F.
Patent NZ-246115-A (NZ)
Title: Aromatic esters of phenylenedialkanoates and pharmaceutical compositions thereof
Inventor: OLEKSYSZYN JOZEF
IPC: C07C69/773
Filed: 1992-12-01
Abstract: Compounds of the formula    <IMAGE>  (I)   <IMAGE> (II)  or   <IMAGE> (III)  wherein: R1, R2, R3 and R4, which may be the same or different, are selected from the group consisting of hydrogen, alkyl of 1-6 carbons, cycloalkyl of 3 to 6 carbons, alkenyl of 2-6 carbons, or together represent methylene groups -(CH2)n-where n is a whole number from 1 to 6, provided that R1 and R2 or R3 and R4 are not both hydrogen; R5 and R6, which may be the same or different, are selected from the group consisting of hydrogen, halogen, nitro or -S(O)nR7 where n is 0, 1 or 2 and R7 is an optionally substituted alkyl of 1-12 carbons atoms; and both Ar substituents are optionally substituted heteroaromatic rings or one Ar is such heteroaromatic ring and the other is optionally substituted phenyl, the optional substitution for Ar being halogen, nitro or -S(O)nR7 where n and R7 have the value given above. The compounds are useful as inhibitors of human neutrophil elastase.
Patent NZ-259534-A (NZ)
Title: Method for cleaning oil contaminated animals using washing agent including foaming and wetting agents
Inventor: BASSERES ANNE
IPC: C11D3/20
Filed: 1994-01-10
Abstract: A washing agent comprising: (a) 1-10 % washing and foaming agent; (b) 5-50 % wetting agent; (c) 0-25 % water-miscible solvent; and (d) the balance consisting of water and optional additives. The use of said agent for cleaning animals soiled by chemical compounds, especially hydrocarbons, is also disclosed.
Patent NZ-264529-A (NZ)
Title: Fibroblast growth factor analogues which have mutations at a heparin binding site
Inventor: LI LU-YUAN
IPC: C12N15/09
Filed: 1994-09-23
Abstract: Structural analogues of fibroblast growth factors have at least one point mutation in a heparin binding site. Typical point mutations are deletions or replacements of basic residues with other residues, e.g., neutral or acidic residues. In some embodiments, the analogues have at least one point mutation in a heparin binding site. Preferred analogues have one or two basic residues replaced by glutamine, and exhibit a binding affinity to cell surface receptors similar or superior to native growth factor, but different heparin binding and biological activity from the native growth factor.
Patent NZ-299605-A (NZ)
Title: Optical communication ring network with add/drop nodes
Inventor: ARECCO FULVIO
IPC: H04J14/02
Filed: 1996-10-17
Abstract: An optical self-healing-ring communication network is described which comprises: a first optical communication line, forming a closed optical path; at least two add / drop nodes for optical signals, optically connected along the line; a second optical communication line forming a closed optical path and optically connected to said optical-signal add / drop nodes. Defined in the network is a first and a second mutually opposite travel directions of the optical signals, with respect to the position of the optical-signal add / drop nodes. At least one of said nodes further comprises selection means, controlled by the optical signals, for the selective dropping of the optical signals from one of the communication lines. At least one of the optical-signal add / drop nodes further comprises means for the simultaneous input of at least one optical signal in the first direction along the first communication line and in the second direction along the second communication line.
Patent NZ-299935-A (NZ)
Title: Use of mammalian hematopoietic faciliatory cells in treating autoimmune diseases
Inventor: ILDSTAD SUZANNE T
IPC: A61K35/28
Filed: 1995-01-24
Abstract: The specification describes the use of a cellular composition comprising mammalian bone marrow cells.  The bone marrow cells are substantially free of graft-versus-host-disease producing cells but retain their hematopoietic faciliatory cells.  The composition is used to treat those suffering from autoimmune diseases.  Specific diseases treated are infantile onset diabetes, multiple sclerosis, systemic lupus erythematosus, HIV, hepatitis and hemoglobinopathies.
Patent NZ-329940-A (NZ)
Title: Air flow unit and assembly, typically as wall mounted fan heater for wall cavity mounting, with front inlets to front and rear of fan
Inventor: COOK DAVID LANGMAN
IPC: F04D29/60
Filed: 1999-03-03
Abstract: Air flows in to the front of the unit (front shown at right of unit) so that air flows to the front of fan 101 and flows to the rear of the fan via duct 105.  Details of wall mounting of the unit are also disclosed.
Patent NZ-333581-A (NZ)
Title: Derivation of pure fine particle silica and pure aluminium hydroxide from clay minerals
Inventor: MCLAUGHLIN ROBERT JAMES
IPC: C01F7/765
Filed: 1997-09-25
Abstract: A process which allows the conversion of clay minerals of the kaolinite group, to a relatively pure form of alumina and silica respectively includes: (a) heating the kaolinite group minerals to greater than 500 °C, which causes dehydroxylation of the crystallographic lattice and formation of an intermediate meta-kaolin; (b) reacting the intermediate with only one of a selection of reagents including acids, alkalines or metalliferous compounds followed by heating of the mixture to form an aluminium salt in solution and residue of silica; (c) separation of the aluminium salt solution from the residue of silica by filtration and further treatment of the silica residue to produce a relatively pure form of fine particled silica; and (d) formation of an alum by addition of ammonium sulphate in solution to the aluminium salt solution and further treatment of the alum to produce a relatively pure form of aluminium hydroxide.
Patent NZ-334503-A (NZ)
Title: Compacting apparatus including a screw conveyor
Inventor: HAMILTON ROBIN
IPC: B30B11/22
Filed: 1997-09-05
Abstract: This waste compaction apparatus (2) has a screw conveyor (4) which conveys material along a passage (6) toward an exit nozzle (10) which constricts the flow, to cause compaction. The screw conveyor (4) is slidably mounted on a shaft (300), biased toward the nozzle (10). This allows the screw conveyor to move axially during compaction to help remove or avoid blockages within the apparatus.
Patent NZ-502344-A (NZ)
Title: Oral cyclosporin compositions wherein it is a suspension of less than 1 micrometer, non-ionic polyoxyalkylene surfactant and one alkanol solvent
Inventor: CHO MOO J
IPC: A61K38/16
Filed: 1996-07-31
Abstract: A method of preparing a pharmaceutical suspension of cyclosporin for administration, whereby the method consists of preparing a concentrated cyclosporin solution consisting essentially of cyclosporin, at least one non-ionic polyoxyalkylene surfactant and at least one alkanol solvent of from 2-3 carbon atoms; and combining said concentrated cyclosporin solution with an aqueous liquid to form said pharmaceutical suspension, wherein at least 50 weight percent of the cyclosporin present is of particles less than about 1 mm. In the subject formulations, cyclosporin is delivered in an orally acceptable vehicle comprising at least one alkanol solvent of from 2 to 3 carbon atoms in combination with at least one non-ionic surfactant. The subject formulations may further comprise at least one co-solvent, where co-solvents of interest include fatty acids and diols. The subject formulations find use in immuno-suppressive therapy.
Patent NZ-503335-A (NZ)
Title: Improvements to mechanical composting
Inventor: BROWN PAUL
IPC: C05F17/02
Filed: 1998-07-20
Abstract: The specification describes a composting system which has: (i) an insulating chamber or chambers and (ii) a base comprising a space and a grate.  The base allows air to flow up, through and around the system and product to be removed. Each chamber or chambers is fitted with a mechanical compost removal mechanism usually in the form of hydraulically operated series of grates.
Patent NZ-503600-A (NZ)
Title: A process for preparing 5-substituted pyrrolo[2,3-d]pyrimidines which provide an aldehyde analogue amendable to isolation
Inventor: KJELL DOUGLAS PATTON
IPC: C07C69/76
Filed: 1998-09-18
Abstract: A process of preparing a compound of the Formula VII comprising: a) Reacting a compound of the Formula IV with a trialkylsilyl halide in a solvent to form a compound of Formula III; b) Halogenating a compound of Formula III to form a compound of Formula V in a solvent; and c) Adding to the product of step (b) a compound of Formula VI; d) Optionally removing carboxy protecting groups from the product of step (c); e) Optionally salifying the product of step (c) or (d) to afford a compound of Formula VII. The compounds of Formula VII have known antifolate activity useful as chemotherapeutic agents for the treatment of cancer. Wherein; R is NHCH(CO2R1)CH2CH2CO2R1 or OR1; and R1 is independently at each occurrence hydrogen or a carboxy protecting group; R2 is NHCH(CO2R3)CH2CH2CO2R3 or OR3; R3 is independently at each occurrence a carboxy protecting group; X is a bond or C1-4alk-diyl; M is a metal cation; n is 1 or 2; halo is chloride, bromide or iodide;
Patent NZ-505011-A (NZ)
Title: Expression vectors and cell lines expressing VEGF-D and method of treating melanomas
Inventor: ACHEN MARC G
IPC: A61P17/02
Filed: 1998-12-23
Abstract: Described are expression vectors comprising VEGF-D and cell lines stably expressing VEGF-D and its biologically active derivatives, and a method of making a polypeptide using these expression vectors in host cells. Also described is the use of VEGF-D in the manufacture of a medicament for treating and alleviating melanomas or tumours expressing VEGF-D and for treating various diseases.
Patent NZ-509789-A (NZ)
Title: Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein
Inventor: PREVOST GREGOIRE
IPC: C12N9/88
Filed: 1999-07-05
Abstract: Use of a cysteine derivative of general formula A for the preparation of a medicament intended to prevent formation of the heterotrimeric G protein where the medicament prepared is intended to treat pathologies which result from the formation of the heterotrimeric G protein, with the exception of cancer and proliferative diseases. The variables R1 to R7, X and Y are as described in the specification
Patent NZ-511254-A (NZ)
Title: A mezzanine floor with removably connected posts, bearers, joists and bracing
Inventor: DAGG HAYDEN MILES
IPC: E04G7/00
Filed: 2001-04-19
Abstract: A demountable mezzanine floor structure constructed of metal, said floor comprising:  at least a pair of spaced apart and elongate load bearing members each being elevated from the ground via at least a pair of upright posts each being detachably fixed at an upper end to the corresponding load bearing member; a plurality of spaced apart floor joists each being detachably fixed and oriented transverse to either said pair of load bearing members or bridging members connected between and oriented transverse to adjacent of the load bearing members; and a plurality of elongate and diagonally oriented bracing members each at opposing ends being detachably coupled to a lower end of one of said posts and a bracing strut at an adjacent of said posts, respectively, said bracing strut being mounted between said pair of load bearing members.
Patent NZ-518348-A (NZ)
Title: Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
Inventor: RIPLEY PAUL HOWARD
IPC: A61K47/44
Filed: 2000-11-20
Abstract: A pleuromutilin derivative of the formula I or a pharmaceutically acceptable salt thereof is used in the manufacture of a medicament for the transdermal treatment of bacterial infections in animals. In formula (I): R1 is ethyl or vinyl; Y is COOH, -CH2-R2 or a group of formula (2); R2 is H, halogen, OH, NH2, SCN, N3, COOH, C(S)S-alkyl, optionally hydroxy substituted -S-pyridyl, optionally substituted alkylthio, -O-SO2-(4-methylphenyl), -S-(CH2)m- X, -(CH2-Z)r-(CH2)s-Q, -S-C(CH3)2-CH2-NH-C(O)-Q or -S- C(CH3)2-CH2-NH-C(O)-CH(NH2)-CH(CH3)2; X, Q and Z are as defined in the specification; m is 0 to 5; r is 0 or 1 and s is 2 to 5.
Patent NZ-520968-A (NZ)
Title: Lipopolysaccharides (LPS) extracted from escherichia coli
Inventor: PROPPERT HANS
IPC: E21D20/00
Filed: 2001-03-20
Abstract: The invention relates to lipopolysaccharides extracted from E. coli DSM 6601. This LPS differs from the known LPS extracted from E. coli in particular with regard to the phosphorylated sugar moiety of the core and to the degree of polymerization of the O-chain.
Patent NZ-521952-A (NZ)
Title: Method and apparatus for electrophysiological assessment of visual function using a head-mounted stereo display
Inventor: GRAHAM STUART
IPC: A61B3/08
Filed: 2001-04-12
Abstract: The multifocal pattern visual evoked potential (VEP) has been adapted to detect visual field loss as a form of objective perimetry, with specific application to glaucoma. Multifocal pattern stimuli are cortically scaled and presented using a standard system. In order to effectively record the visual field responses, a unique array of bipolar occipital straddle electrode positions are employed, overlying the occipital visual cortex. Multi- channel VEP recording is then performed using these electrode positions. The responses are combined from the channels to produce a representation of the visual up to 25 DEG of eccentricity. Analysis of results to detect early field defects is enhanced by asymmetry analysis between fellow eyes, and by a scaling algorithm to compensate for inter-individual variations. VEP objective perimetry corresponds well with subjective Humphrey visual field defects, showing loss of signal in the areas of visual field loss. Further, it shows reductions in areas of the visual field in glaucoma suspects where subjective testing is still within normal limits. This technique represents the first practical application of the multifocal pattern VEP to objective detection of visual field defects in glaucoma, and may have the potential for detecting disease at an earlier stage than conventional testing.
Patent NZ-525040-A (NZ)
Title: Gaming device and method having a plurality of serially dependent and independent bonuses
Inventor: WEISS STEVEN A
IPC: A63F13/10
Filed: 2001-09-12
Abstract: A gaming device comprises wager accepting means, a display and processor means for operating the display as a function of a player activating the wager accepting means by placing a wager. A primary game on the display has a first and a second particular outcome thereon, and first and second bonus games. The first bonus game is accessed via the first particular outcome on the primary game, and the second bonus game is accessed by the second particular outcome, and the first bonus game is embodied as a pathway and includes an outcome at a terminus of the pathway to play the second bonus game.
Patent NZ-527395-A (NZ)
Title: A plastic clip and post assembly
Inventor: RIDLEY PAUL JAMES CHRISTOPHER
IPC: E04H17/10
Filed: 2003-08-05
Abstract: Methods and apparatus for holding wire to a metal or fibre reinforced post are disclosed. A plastic clip 17 with wire locating means 19 is held against the side of a metal or fibre reinforced plastic post. Either a ballistic nail or ballistic screw is fired through the plastic clip and into the post to locate the clip in position.
Patent NZ-527903-A (NZ)
Title: Illumination device for simulation of neon lighting
Inventor: CLEAVER MARK J
IPC: F21S4/00
Filed: 2001-12-11
Abstract: An illumination device (10) for simulating neon lighting comprising a plurality of space point light sources (24) positioned adjacent a lateral light receiving surface (15) of a substantially rod-like waveguide (12) made of a material that preferentially scatters light entering the light receiving surface such that the light intensity pattern exiting a lateral light emitting surface (13) of the waveguide (12) has a substantially uniform light intensity pattern.
Patent NZ-529060-A (NZ)
Title: High power rotary transformer with bus duct assembly
Inventor: WHITE MICHAEL WALTER
IPC: H02K13/02
Filed: 2003-02-20
Abstract: A rotary transformer has a bus duct assembly 27, 31 that extends through the hollow shaft 28 of the rotary transformer from collector or slip rings 40 positioned above a drive motor 30 for the transformer to end windings 14 of the rotor 22 positioned most remote from the drive motor. By positioning the leads of the bus duct connection with the rotor end windings on the rotor end windings most remote from the drive motor, the shaft strength and integrity is not reduced due to the torque applied by the drive motor. Further, the shaft is formed from two coupled shaft sections and the bus duct assembly comprises two L shaped sections each positioned substantially within a corresponding shaft section. The bus duct sections are interconnected to complete the bus duct assembly making it simpler to remove the first or upper shaft section from the second or lower shaft section during field servicing.